Weighing the adverse cardiac effects of fluoroquinolones: A risk perspective

Risks of Cardiac Arrhythmia and Mortality Among Patients Using New-Generation Macrolides, Fluoroquinolones, and β-Lactam/β-Lactamase Inhibitors: A Taiwanese Nationwide Study

(2014) Hsu-Wen Chou et al.   CLINICAL INFECTIOUS DISEASES

Thorough QT study of the effect of oral moxifloxacin on QTcinterval in the fed and fasted state in healthy Japanese and Caucasian subjects

(2013) Jorg Taubel et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Effect of Combined Fluoroquinolone and Azole Use on QT Prolongation in Hematology Patients

(2012) John D. Zeuli et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Fluoroquinolones and the Risk of Serious Arrhythmia: A Population-Based Study

(2012) F. Lapi et al.   CLINICAL INFECTIOUS DISEASES

Azithromycin and the Risk of Cardiovascular Death

(2012) Wayne A. Ray et al.   NEW ENGLAND JOURNAL OF MEDICINE

Strategies to reduce the risk of drug-induced QT interval prolongation: a pharmaceutical company perspective

(2008) C E Pollard et al.   BRITISH JOURNAL OF PHARMACOLOGY